GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 89 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $79,000 | -36.8% | 16,427 | -20.4% | 0.00% | -33.3% |
Q3 2019 | $125,000 | -72.8% | 20,627 | -68.2% | 0.01% | -78.6% |
Q1 2019 | $460,000 | +22.7% | 64,911 | +27.0% | 0.03% | +64.7% |
Q3 2018 | $375,000 | -11.3% | 51,113 | -22.9% | 0.02% | 0.0% |
Q2 2018 | $423,000 | -40.3% | 66,313 | -49.1% | 0.02% | -39.3% |
Q1 2018 | $708,000 | +238.8% | 130,214 | +159.4% | 0.03% | +211.1% |
Q4 2017 | $209,000 | -48.5% | 50,190 | +58.3% | 0.01% | -52.6% |
Q1 2017 | $406,000 | -41.6% | 31,700 | -44.2% | 0.02% | -53.7% |
Q4 2016 | $695,000 | +281.9% | 56,800 | +266.5% | 0.04% | -30.5% |
Q3 2016 | $182,000 | -42.0% | 15,500 | -74.1% | 0.06% | +321.4% |
Q1 2016 | $314,000 | -51.9% | 59,748 | -29.1% | 0.01% | -54.8% |
Q4 2015 | $653,000 | +26.1% | 84,248 | +111.0% | 0.03% | +72.2% |
Q1 2015 | $518,000 | +165.6% | 39,923 | +83.1% | 0.02% | +100.0% |
Q3 2014 | $195,000 | -44.4% | 21,799 | -38.3% | 0.01% | -52.6% |
Q1 2014 | $351,000 | -40.1% | 35,350 | -37.7% | 0.02% | 0.0% |
Q2 2013 | $586,000 | – | 56,705 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|